• Users Online: 129
  • Print this page
  • Email this page


 
 Table of Contents  
EDITORIAL
Year : 2018  |  Volume : 1  |  Issue : 1  |  Page : 1

Preface from Editor-in-Chief


Department of Neurosurgery/Neuro-oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China

Date of Web Publication28-Feb-2018

Correspondence Address:
Dr. Zhong-Ping Chen
Department of Neurosurgery/Neuro-oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong
China
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/glioma.glioma_7_18

Rights and Permissions

How to cite this article:
Chen ZP. Preface from Editor-in-Chief. Glioma 2018;1:1

How to cite this URL:
Chen ZP. Preface from Editor-in-Chief. Glioma [serial online] 2018 [cited 2022 Nov 30];1:1. Available from: http://www.jglioma.com/text.asp?2018/1/1/1/226435

It is with great excitement that we announce the establishment of the journal Glioma, a bimonthly publication devoted to the neuro-oncology field, with a particular focus on glioma. As readers, you may wonder with several neuro-oncology journals already in existence, why did we still want to create Glioma?

Gliomas are the most frequent primary tumors of the central nervous system. However, despite the extensive research around the world on effective treatment strategies, the prognosis of glioma patients remains unsatisfactory. With advances in basic research and scientific technologies, novel therapeutic options demonstrate great potential in improving the treatment outcomes of glioma patients. There has been a rapid emergence of breakthroughs in glioma-related research, and these findings are being published in a wide range of journals, not just neuro-oncology journals. Our hope is that Glioma may provide a specific platform for discussion and communication among basic scientists and clinicians.

As an official journal launched by the Chinese Society of Neuro-Oncology, our aim is to not only connect the people working in this field within China but also reach out to global scientific communities. We sincerely welcome clinicians and researchers to submit their high-quality work to us. Being an online open access journal, we will definitely provide an easier and faster communication for the fields.

We anticipate that the launching of Glioma will be a great opportunity to bring together researchers in this field to collaborate together to fight this challenging disease and improve patient care.






 

Top
 
 
  Search
 
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

 
  In this article

 Article Access Statistics
    Viewed2916    
    Printed209    
    Emailed0    
    PDF Downloaded343    
    Comments [Add]    

Recommend this journal


[TAG2]
[TAG3]
[TAG4]